Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 128 citing articles:

Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma
Ruiping Wang, Minghao Dang, Kazuto Harada, et al.
Nature Medicine (2021) Vol. 27, Iss. 1, pp. 141-151
Open Access | Times Cited: 194
Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility
Mihnea P. Dragomir, Scott Kopetz, Jaffer A. Ajani, et al.
Gut (2020) Vol. 69, Iss. 4, pp. 748-763
Closed Access | Times Cited: 172
Update on gastric cancer treatments and gene therapies
Alessio Biagioni, Ileana Skalamera, Sara Peri, et al.
Cancer and Metastasis Reviews (2019) Vol. 38, Iss. 3, pp. 537-548
Closed Access | Times Cited: 164
Revealing the transcriptional heterogeneity of organ‐specific metastasis in human gastric cancer using single‐cell RNA Sequencing
Haiping Jiang, Dingyi Yu, Penghui Yang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 153
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
Guangchun Han, Guoliang Yang, Dapeng Hao, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 141
Mapping the genomic diaspora of gastric cancer
Khay Guan Yeoh, Patrick Tan
Nature reviews. Cancer (2021) Vol. 22, Iss. 2, pp. 71-84
Closed Access | Times Cited: 122
The immune microenvironment in gastric adenocarcinoma
Yana Zavros, Juanita L. Merchant
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 7, pp. 451-467
Open Access | Times Cited: 96
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
Giovanni Fucá, Romain Cohen, Sara Lonardi, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 2, pp. e004001-e004001
Open Access | Times Cited: 81
Single-cell sequencing: a promising approach for uncovering the mechanisms of tumor metastasis
Yingying Han, Dan Wang, Lushan Peng, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 71
Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial
Beate Rau, Hauke Lang, Alfred Koenigsrainer, et al.
Journal of Clinical Oncology (2023) Vol. 42, Iss. 2, pp. 146-156
Open Access | Times Cited: 59
Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis
Xuanzhang Huang, Min-Jiao Pang, Jiayi Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 50
An atlas of epithelial cell states and plasticity in lung adenocarcinoma
Guangchun Han, Ansam Sinjab, Zahraa Rahal, et al.
Nature (2024) Vol. 627, Iss. 8004, pp. 656-663
Open Access | Times Cited: 50
Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development
Tadahito Yasuda, Yanru Wang
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 627-642
Open Access | Times Cited: 32
Recent advances in treating oesophageal cancer
Kazuto Harada, Jane E. Rogers, Masaaki Iwatsuki, et al.
F1000Research (2020) Vol. 9, pp. 1189-1189
Open Access | Times Cited: 97
Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity
Inna M. Yasinska, N. Helge Meyer, Stephanie Schlichtner, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 80
Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities
Yosuke Tanaka, Fumiko Chiwaki, Shinya Kojima, et al.
Nature Cancer (2021) Vol. 2, Iss. 9, pp. 962-977
Closed Access | Times Cited: 66
Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
Yong Xiang Gwee, Daryl Kai Ann Chia, Jimmy Bok Yan So, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 24, pp. 2830-2830
Open Access | Times Cited: 59
Advances in the management of peritoneal malignancies
Vahan Képénékian, Aditi Bhatt, Julien Péron, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 11, pp. 698-718
Closed Access | Times Cited: 56
Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment
Yibo Fan, Yuan Li, Xiaodan Yao, et al.
Gut (2022) Vol. 72, Iss. 4, pp. 624-637
Closed Access | Times Cited: 49
The molecular biology of peritoneal metastatic disease
Sanne Bootsma, Maarten F. Bijlsma, Louis Vermeulen
EMBO Molecular Medicine (2023) Vol. 15, Iss. 3
Open Access | Times Cited: 30
Early stage gastric adenocarcinoma: clinical and molecular landscapes
Yuki Hirata, Ayesha Noorani, Shumei Song, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 453-469
Closed Access | Times Cited: 30
Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases
Joseph J. Zhao, Chin‐Ann Johnny Ong, Supriya Srivastava, et al.
Gastroenterology (2024) Vol. 167, Iss. 7, pp. 1384-1398.e4
Open Access | Times Cited: 12
Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target
Minpu Zhang, Cun Liu, Li Ye, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 11
Open Access | Times Cited: 10
Educational Review: Updates on Therapeutic Strategies for Gastric Cancer with Peritoneal Metastasis
Kate Lewis, Laurence P. Diggs, Brian D. Badgwell
Annals of Surgical Oncology (2025)
Closed Access | Times Cited: 1
Molecular mediators of peritoneal metastasis in pancreatic cancer
Leela Rani Avula, Brendan Hagerty, Christine Alewine
Cancer and Metastasis Reviews (2020) Vol. 39, Iss. 4, pp. 1223-1243
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top